Podcast
AHF Podcast
Hosted by Anterior Hip Foundation · EN
The AHF Podcast features thoughtful conversations about orthopedic surgery, outcomes, and clinical decision-making, with a particular focus on hip surgery and related innovation.
Produced by the Anterior Hip Foundation, the podcast brings together surgeons, researchers, and clinical leaders to examine how evidence, experience, and real-world practice intersect. Episodes explore what the data actually shows, where assumptions break down, and how clinicians navigate uncertainty in daily practice.
This podcast is intended for orthopedic surgeons, trainees, and medically literate clinicians who value nuanced discussion, critical thinking, and honest examination of what improves patient care.
17episodes
Episodes
Newest firstAll episodes
From Idea to Market: Ep 10 - What Breaks at Scale
2w ago00:32:08Tap to summarizeSend us Fan MailWhat real-world use reveals about a medical device that no clinical trial ever could — and why the most dangerous moment in med tech innovation often comes after success, not before. A conversation about the fatigue failures, reimbursement gaps, and feedback breakdowns that surface only at scale.For ten episodes, the From Idea to Market series has followed medical innovation through every threshold an idea must survive — the first clinical insight, the years of iteration, the funding rounds, the regulatory climb, the investor's decision room. Episode 10 asks what happens after all of that succeeds. When a product is working, when demand is building, when expectations have risen, what new vulnerabilities does that very success create?Joe Schwab is joined by four voices who have lived this stage from different positions. Jared Foran is an orthopaedic surgeon in Denver and co-founder and chief scientific officer of Forcast Orthopedics. Doug Fairbanks is the president, CEO, and board member at VISIE Inc. Charlie DeCook is the president of Total Joint Specialists, a 17-surgeon group in Atlanta. Robert Cohen is the vice president of innovation and technology for Stryker's orthopaedic group, with four decades of watching the commercial environment for med tech innovation shift around him.The episode works through three questions: what does real-world use reveal that no development program ever can, which structural and commercial weaknesses surface only at scale, and how do teams build the organizational discipline to act on what the market tells them. The conversation moves from product iteration after launch, to the second valley of death between regulatory clearance and reimbursement, to the feedback loops inside an organization that determine whether real-world signals reach the people who can act on them. For surgeon-founders, for engineers in med tech, and for anyone trying to understand why so many clinically promising ideas stall after they reach the market, this episode is about what scale actually demands.⏱️ Chapters:00:00 What happens to medical devices after they reach the market02:53 Surgeons and industry leaders who scaled med tech innovations04:35 The fatigue failure principle applied to medical devices06:05 What real-world use reveals that clinical trials never can09:15 Why most med tech products require a major pivot post-launch11:33 How to sustain commercial momentum after launch14:32 The second valley of death between clearance and reimbursement16:13 Inside the new FDA-CMS RAPID coverage pathway17:36 How reimbursement uncertainty kills good clinical ideas22:35 Building feedback loops before scale exposes the gaps25:39 Why launch is the start of development, not the end30:55 Preview: built to last or built to sellListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#anteriorhipfoundation #AHFPodcast #MedTech #MedTechInnovation #FromIdeaToMarket #PostMarketSurveillance #MedicalDevices #Reimbursement #FDA #ValleyOfDeath #Stryker #OrthopedicSurgery
Transcribe →FITM Extended Interview: Alexander Sah
2w ago00:23:23Tap to summarizeSend us Fan MailAlex Sah on what it actually takes for a practicing surgeon to develop new orthopaedic tools — from first idea to OR adoption.An honest conversation about mentors, mistakes, AI, and knowing when to walk away from a collaboration.Most surgeons spot problems in the OR daily and quietly adapt to the limits of existing tools. Alex Sah, a high-volume hip and knee surgeon in Silicon Valley and Chief Medical Officer at Think Surgical, has chosen instead to engage directly with industry — first as an evaluator, then as an advisor, and eventually as a design partner. In this conversation with Joe Schwab, he walks through how that progression actually works in practice, and why he thinks every surgeon with a good idea owes it to themselves to start the process now rather than later.The discussion gets practical fast. Alex breaks down how to vet an idea with a mentor and a patent search, why timing and portfolio fit can make or break a great concept, how to set milestones that let you walk away gracefully from a stalled collaboration, and why the technologies that succeed are usually the ones that speak for themselves the first time a surgeon uses them. He also shares a small habit with big implications — keeping his OR team blinded when testing new products to neutralize the placebo effect that quietly distorts informal evaluations.The conversation closes on AI's inevitable arrival in orthopaedics, the surgeon's role in shaping it before it gets shaped for us, and the AHF Shark Tank as a live laboratory for the From Idea to Market journey. If you've been sitting on an idea, or wondering whether to take that next call from a device rep with a prototype, this episode is a realistic map of the road ahead.⏱️ Chapters:00:00 Introduction and Silicon Valley innovation roots01:02 Why surgeons should solve problems instead of adapting03:25 Surgeon roles in product development04:24 First steps for surgeons with no industry connections05:41 Turning a clinical idea into a development concept06:46 Setting milestones and knowing when to walk away08:01 Lessons from working with Think Surgical10:50 Evaluating new surgical technology objectively12:14 Essential advice for first-time surgeon innovators15:47 Why surgeons must help shape AI in orthopaedics17:40 Inside the AHF Shark Tank for surgical innovationListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #AlexanderSah #SurgeonInnovator #MedicalDeviceDevelopment #ThinkSurgical #Ospitek #OrthopaedicInnovation #JointReplacement #HipAndKneeSurgery #AIinSurgery #FromIdeaToMarket #MedTech #SurgicalRobotics
Transcribe →From Idea to Market: Ep 9 - Inside the Decision Room
3w ago00:33:17Tap to summarizeSend us Fan MailWhat med tech investors and strategic acquirers actually evaluate when a founder walks into the room — and what separates the pitches that earn capital from those that don't. A conversation drawn from people who've sat on both sides of the table.For nine episodes, the From Idea to Market series has followed innovation from the founder's perspective — the problem noticed in a clinic, the iteration through years of prototypes, the regulatory climb, the manufacturing scale-up. Episode nine flips the lens. For the first time, the conversation moves into the room where decisions about that founder get made: by investors, by strategic acquirers, by the people whose capital and reputation come along with a yes.Joe Schwab is joined by voices who've lived this evaluation from every side. Charles Lawrie is a co-founder and chief medical officer at FIOS Health and the current president of the Anterior Hip Foundation. Charlie DeCook is the president of Total Joint Specialists and has watched dozens of Shark Tank pitches at AHF annual meetings. Alex Sah is past AHF president, chief medical officer at Think! Surgical, and chief innovation officer at Ospitek. Robert Cohen, vice president of innovation and technology for Stryker's orthopaedic group, has spent four decades evaluating med tech ideas from inside startups and from inside one of the largest companies in the field.The episode unpacks three questions: what truly drives the decisions made behind closed doors, how clinical value and financial logic and strategic interest actually intersect in real time, and which kinds of narrative survive due diligence — and which collapse the moment scrutiny begins. For surgeon-founders preparing to pitch, for clinicians thinking about their first innovation, and for anyone curious about how med tech capital actually gets allocated, this episode lays out what the decision room is really testing.⏱️ Chapters:00:00 Why this episode flips perspective from founder to investor02:42 Surgeons and industry leaders inside the med tech decision room04:46 What investors actually look for in a med tech pitch08:23 How to structure a 15-minute med tech pitch13:30 Where clinical value, profit, and strategy intersect15:30 Why a great med tech idea can fail to scale18:36 Why founders should pitch with a CEO at their side22:02 How honest narrative wins under due diligence scrutiny26:40 Stick to your competency: advice from a Stryker VP29:12 What the decision room is really testing31:43 Preview: when scaling success threatens to break the companyListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #MedTech #MedTechInnovation #FromIdeaToMarket #MedicalDevices #MedTechInvesting #OrthopedicSurgery #StartupPitch #VentureCapital #Stryker #SharkTank
Transcribe →FITM Extended Interview: Charles Lawrie (FIOS Health)
3w ago00:31:55Tap to summarizeSend us Fan MailCharles Lawrie, MD — president of the Anterior Hip Foundation and a high-volume anterior approach hip and robotic knee surgeon in Miami — walks us through how a frustration in his own clinic became FIOS Health, an AI-powered patient communication platform now used in orthopaedic practices across the United States. This is an extended From Idea to Market conversation about the often lonely process of turning a clinical observation into a commercialized med-tech product, and what surgeons should know before they try.Most surgeons see the same pattern every week: a flood of routine post-op questions about swelling, walking, showering, and driving that consumes clinic staff and amplifies patient anxiety. Lawrie's argument is that the bottleneck isn't surgical expertise — it's access to timely, trusted information, and that scaling that information is a fundamentally different problem than scaling clinical capacity.We get into why he chose an AI-first product layered on familiar SMS and WhatsApp instead of yet another app, how he found a complementary co-founder in engineer and serial entrepreneur Andrew McDaid, what he had to unlearn to translate clinical expertise into product-market fit, and where FIOS Health is heading next — from answering patient questions to acting as an intelligence layer for the entire clinic.If you're a surgeon thinking about innovation, this is a candid look at what it actually involves: starting with a problem you live every day, resisting the urge to build alone, defining a minimum viable product, and sitting with the daily self-doubt that comes with taking an idea to market.https://fioshealth.com/⏱️ Chapters:00:00 Introducing Charles Lawrie and FIOS Health01:14 Why patients struggle with information access after surgery03:26 Solving staff scarcity and patient anxiety at the same time05:43 Why AI plus SMS beats yet another patient app08:53 Turning a clinical observation into a startup13:07 The mahogany desk vision for patient care18:21 Finding product market fit in a busy clinic22:41 How FIOS becomes a surgeon's digital twin26:50 Advice for surgeons who want to build a company29:43 The intelligence layer for the entire clinicListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #FIOSHealth #CharlesLawrie #FromIdeaToMarket #MedTechStartup #OrthopaedicInnovation #AIinHealthcare #PatientEngagement #HipArthroplasty #SurgeonEntrepreneur #DigitalHealth #ClinicalWorkflow
Transcribe →From Idea to Market: Ep 8 - Built to Run
4w ago00:38:49Tap to summarizeSend us Fan MailWhat does it actually take to move a medical device from a working prototype to a product that can be built reliably at volume? In this episode of From Idea to Market, surgeons, founders, and attorneys describe the discipline that separates an approved device from a scalable company.Most medical device teams underestimate what happens after a prototype works. Manufacturing at scale is a different problem from manufacturing at all, and the assumption that the hard work is done once the device is validated tends to be the most expensive miscalculation in med tech. This episode unpacks the transition from a hand-tuned engineering project to a controlled, reproducible production system, and why the process itself, not the device, becomes the real product.Jared Foran of Forcast Orthopedics, Leo Whiteside, Marie-Isabelle Batthyány of XRSynergies, Charles Lawrie of FIOS Health, Charlie DeCook of Total Joint Specialists, attorney Emily Ast, and Simon Mifsud of Garland Surgical share what they have learned from inside this transition. The conversation covers ISO 13485, design for manufacturability, supplier qualification, the economics of hardware versus software, supply chain design as part of the device itself, the kinds of problems that only surface at volume, and the contract clauses that quietly determine whether a successful product remains a fair deal once it scales globally.If you build, fund, regulate, or use medical devices, this episode is for you. It is the part of innovation that gets the least attention and decides the most outcomes — the daily, unglamorous work of building systems reliable enough that the product performs the same way every time, no matter who is in the room.⏱️ Chapters:00:00 Why scaling production breaks medical devices02:57 Meet the founders, surgeons, and attorneys05:30 What design freeze means in medical devices06:46 Why the process becomes the product, not the device09:32 Bringing manufacturing partners in before design freeze12:18 The three-times rule of medical device development15:59 Quality, cost, and scalability at production scale18:02 Why hardware med tech is harder than software20:18 Designing surgical kits for real-world supply chains25:22 Problems that only emerge at production volume28:11 Why founders should titrate the speed of scale30:45 IP clauses and royalty timing for global products34:58 What scale really proves about a medical device companyListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #FromIdeaToMarket #MedTech #MedicalDeviceDevelopment #ISO13485 #DesignForManufacturability #DFM #QualityManagementSystem #MedTechScaling #OrthopedicInnovation #SurgicalInnovation #MedicalDeviceManufacturing #MedTechFounders
Transcribe →FITM Extended Interview: Emily Ast
May 100:35:01Tap to summarizeSend us Fan MailThere is no such thing as an off-the-record innovation discussion. Even a casual conversation over drinks can create a factual record of idea sharing that impacts patent ownership, joint development leverage, and your negotiating position for years. Emily Ast, a contract attorney whose practice is 75 percent orthopedics, explains exactly what surgeon innovators need to know before they say a word to anyone — including friends and family.Ast breaks down the two main contract types innovators encounter: general consulting agreements and intellectual property development agreements. She identifies the single clause she sees surgeons consistently underestimate — the product or project scope definition — and shows how a description that is even slightly too broad can transfer far more IP than intended while limiting what the innovator can do with other companies. She walks through how work orders and statements of work can keep scope appropriately narrow, why royalty streams need to account for different regulatory timelines across global markets, and how to structure IP compensation so it qualifies for capital gains treatment rather than ordinary income.The conversation also covers what a healthy, well-balanced IP partnership actually looks like, why companies may be shifting away from long royalty streams toward milestone payments and flat-rate structures, and the single most common mistake Ast sees innovators make: getting excited and signing a two-year agreement covering all of hip and knee arthroplasty when they were only asked to do one product lab. For any surgeon sitting on an idea, this is the legal foundation you need before your first meeting.https://www.astcontracts.com/⏱️ Chapters:00:00 Meet Emily Ast — contract attorney for surgeon innovators01:06 Role of a contract attorney in early-stage innovation01:55 The biggest mindset shift: no off-the-record discussions02:45 Why you need an NDA before talking to anyone04:40 Risks of sharing ideas without protection07:15 The most underestimated clause: product scope definition09:23 General consulting agreements and hidden IP transfer11:00 How work orders keep scope appropriately narrow13:58 Key negotiation points for your first consulting agreement15:25 IP development agreements: royalties, equity, and structure17:36 Tax benefits of properly structured IP compensation18:45 What happens when your IP appears in a product variation21:40 Regional royalty timing across global markets24:03 What a healthy IP partnership looks like27:17 The most common mistake innovators make with industry28:16 Foundational preparation before meeting with a company29:52 One piece of advice: protect your napkin idea31:42 How the surgeon-industry relationship is evolving34:16 What "from idea to market" means: get your team in placeListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #SurgeonInnovator #IntellectualProperty #MedicalDeviceContracts #PhysicianEntrepreneur #NDA #RoyaltyAgreement #OrthopedicInnovation #EmilyAst #IPProtection #ConsultingAgreement #MedTechLaw #FromIdeaToMarket
Transcribe →FITM Extended Interview: XRS Medical (Marie-Isabelle Batthyány)
Apr 2800:48:42Tap to summarizeSend us Fan MailA patient had already signed every document — but no one had told her she would lose her stomach. That moment early in her anesthesia training convinced Marie-Isabelle Batthyány that informed consent was fundamentally broken. Years later, she built XRS Medical, a VR platform that replaces paper consent forms with immersive, avatar-delivered patient education and tracks attention in real time using a patented eye-tracking algorithm.Batthyány walks through exactly what happens from the moment a patient puts on the headset to the moment an attention evaluation report is generated for the surgeon's file. The numbers back it up: 84 percent recall accuracy and 87.5 percent patient satisfaction versus paper forms that almost nobody reads. The platform creates photorealistic digital twins of the operating surgeon, delivers the explanation in the patient's native language, and produces a legal record that the information was delivered and attended to. With over 4,000 patient uses across Austria, Switzerland, Poland, and France, XRS Medical has moved well past proof of concept.The business story is equally sharp. Batthyány designed the company for acquisition from day one — lean team, phantom shares program, three distinct revenue streams across healthcare providers, pharma, and medical device manufacturers. A surprise pivot into clinical trial consent with Boehringer Ingelheim turned out to be one of the strongest product-market fit moments of the journey. For clinician-founders navigating the European fundraising landscape with a disruptive technology, her playbook on investor fit, due diligence readiness, and the "three threes" rule is essential listening.https://www.xrs-medical.com/⏱️ Chapters:00:00 Meet Marie-Isabelle Batthyány — anesthesiologist turned founder03:00 The patient who didn't know she would lose her stomach06:04 From clinical frustration to founding XRS Medical07:23 Why paper forms and traditional videos fail patients09:28 How the VR informed consent workflow actually works14:40 The eye tracking algorithm and US patent19:40 Early prototypes — from real VR film to digital avatars26:04 Designing a company for acquisition from day one28:24 Ideal acquirers: pharma, hospital groups, and three revenue streams34:41 Advantages of being a physician-led European startup37:04 How the core team came together39:41 What medical school never taught about business46:02 Where XRS Medical is heading: US, Japan, AI avatars48:08 Advice for future clinician-founders49:05 What "from idea to market" means: blood, sweat, tearsListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #XRSMedical #InformedConsent #VirtualReality #PatientEducation #EyeTracking #MedTechStartup #DigitalHealth #ClinicalTrialConsent #MarieIsabelleBatthyany #ClinicianFounder #MedicalLegalRisk #VRinHealthcare
Transcribe →FITM Extended Interview: Simon Mifsud (Garland Surgical, Ltd.)
Apr 2400:35:31Tap to summarizeSend us Fan MailGarland Surgical's flagship product, the TriActiv Hip (formerly known as the MaltaHip), replaces the ball-and-socket geometry that has defined hip arthroplasty for 120 years with a cylindrical bearing system inspired by the biomechanics of the ankle joint. Simon Mifsud, CEO of Garland Surgical, explains how this design virtually eliminates dislocation risk and reduced wear by 75 percent in accelerated testing.Mifsud walks through how the cylindrical design achieves its stability advantage — larger contact area, linear reciprocating motion that avoids cross-shear of the polymer — and why surgeons at AAOS and ACUS told him stability matters far more to them right now than durability. He describes the four patient populations this technology targets, from chronic dislocators and post-spinal-fusion patients to the roughly half of the global population whose daily activities involve squatting and cross-legged sitting. The TriActiv Hip stays in place through all of it while offering range of motion that constrained liners cannot match.https://www.garlandsurgical.health/The business story is just as instructive. Garland Surgical is a University of Malta spinout navigating a pre-revenue funding landscape where deep-tech hardware competes against AI and digital health for investor attention. Mifsud shares how a hybrid of equity and non-dilutive grant funding — including a 1.4 million euro Malta Enterprise award — has kept the company moving, and how a successful FDA Q-sub cleared the biggest objection investors had. For innovators building physical devices in a software-obsessed market, this is a roadmap worth studying.⏱️ Chapters:00:00 Introducing Simon Mifsud and the TriActiv Hip00:49 Why ankle biomechanics inspired a new hip design02:54 Four underserved patient populations06:19 How cylindrical bearings reduce wear debris08:18 What "a hip for life" really means09:41 Proof of concept: cadaver surgery and the garland pose11:03 Cross-compatibility with existing femoral stems13:11 Licensing model versus becoming an OEM15:04 FDA 510(k) pathway and regulatory strategy16:01 UK launch, ODEP, and training early adopters17:26 Funding a hardware startup in a software-first market20:23 How investor feedback shaped the regulatory approach23:15 What surgeons at AAOS and ACUS actually wanted26:46 Managing relationships with academic co-inventors29:26 Where the TriActiv Hip fits in five years33:27 What "from idea to market" means to Garland SurgicalListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #TriActivHip #GarlandSurgical #HipReplacement #TotalHipArthroplasty #THA #HipDislocation #CylindricalBearing #MedicalDeviceStartup #SimonMifsud #HipForLife #510k #OrthopedicInnovation
Transcribe →From Idea to Market: Ep 7 - Beyond Clearance
Apr 1700:40:26Tap to summarizeSend us Fan MailYour device just got FDA clearance. So why isn't anyone using it? In this episode of From Idea to Market, Joe Schwab and a panel of surgeons, engineers, and MedTech leaders explore why regulatory approval is only the beginning — and what it actually takes to earn a place in the operating room.Clearance tells you a device is safe and effective. It doesn't tell you whether a busy surgeon will change their workflow, whether a procurement committee will approve it, or whether a hospital can absorb it into daily practice. This episode unpacks the gap between permission and performance — the space where most MedTech innovations either earn trust or stall out.Drawing on Everett Rogers' Diffusion of Innovations theory and recent research on early adoption decision-making in surgery, the conversation examines why clinical evidence alone isn't enough. Guests describe how simplicity, immediate benefit, team dynamics, and peer influence determine whether a technology sticks — and why the intention-behavior gap in surgical practice is wider than most companies expect.The panel also explores how success is redefined after clearance, moving from trial endpoints to real-world outcomes including patient satisfaction, complication rates, workflow efficiency, and health economics. In the PJI space alone, annual hospital costs are projected to reach $1.85 billion by 2030, giving technologies that move the needle enormous clinical and economic significance.⏱️ Chapters:00:00 Introduction and series overview02:34 Meet the panel05:47 Why clearance is only the beginning07:42 Diffusion of innovations in surgery11:07 Investing in data vs inventory after clearance16:11 The intention-behavior gap in adoption18:14 Deliberate rollout and early adopter strategy20:55 Simplicity as the key to surgical adoption23:18 Market forces behind technology uptake26:19 Redefining success outside controlled settings29:24 PJI economics and the case for innovation33:19 When innovation becomes the standard of care36:52 Three lessons from life after clearanceListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #MedTechAdoption #RegulatoryStrategy #FDAClearance #DiffusionOfInnovations #SurgicalInnovation #TotalHipArthroplasty #PJI #PeriprostheticJointInfection #RealWorldEvidence #OrthopedicSurgery #FromIdeaToMarket #MedicalDeviceAdoption
Transcribe →FITM Extended Interview: Charlie DeCook
Apr 1400:29:44Tap to summarizeSend us Fan MailCharlie DeCook has exited seven medical device companies while performing 1,500 joint replacements a year — all packed into three clinical days per week. In this extended interview, he breaks down exactly how he evaluates new technologies and why he now filters every opportunity through an AI and robotics lens.DeCook traces his entrepreneurial arc from his first venture in surgical impaction — a product that eventually sold to Johnson & Johnson and became Kincise — through to his current focus on software-driven solutions. He explains why the "jobs to be done" framework from Clayton Christensen's Innovator's Dilemma is the foundation of every product he touches, and why surgeons who skip the financial model are setting themselves up for years of pain. Along the way, he offers a candid look at how large device companies operate, including the "slow no" that strings inventor-surgeons along for months without a real commitment.The conversation also covers the AHF Shark Tank program and what separates pitches that land from those that get eaten alive. Whether you are a surgeon sitting in the OR frustrated with an inefficiency, or a founder trying to get traction with the big three, DeCook's hard-won playbook is worth hearing in full.⏱️ Chapters:00:00 Meet Charlie DeCook — surgeon, serial entrepreneur02:11 First venture: surgical impaction to Johnson & Johnson03:29 Filtering ideas with easier, faster, better05:22 Patient outcomes vs commercial reality in med-tech07:43 Why cost concerns work themselves out over time09:02 Strategic shift from hardware to AI and robotics10:41 Finding innovation through jobs to be done in the OR12:43 Lessons from ventures that required major pivots14:49 Protecting IP from large device companies17:27 Why public companies can't think past the quarter19:02 Evaluating products beyond your own efficiency lens21:40 What makes a winning AHF Shark Tank pitch24:29 Common mistakes surgeon-entrepreneurs make pitching27:17 Innovation areas the Shark Tank needs more of29:25 Top advice for surgeons with a great OR idea31:45 What innovation in orthopedics really meansListen to the AHF Podcast on your preferred platform:Buzzsprout: https://ahfpodcast.buzzsprout.comApple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHcLinkedIn: https://www.linkedin.com/showcase/ahf-podcastYouTube: https://www.youtube.com/@anteriorhipfoundationHomepage: https://anteriorhipfoundation.comThis podcast is intended for educational and informational purposes only.The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion.#AnteriorHipFoundation #AHFPodcast #SurgeonEntrepreneur #MedicalDeviceStartup #OrthopedicInnovation #TotalJointArthroplasty #SurgicalImpaction #AIinOrthopedics #RoboticSurgery #JobsToBeDone #AHFSharkTank #CharlieDeCook #MedTechEntrepreneur #THA
Transcribe →